Corundum Trust Company’s Organon & Co OGN Stock Holding History

Corundum Trust Company’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-127	Closed	-$1.36K	–	96
2025 Q3	$1.36K	Buy	+127	New	+$1.25K	﹤0.01%	126

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

KBG

Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Corundum Trust Company's OGN Position: Q4 2025 in Review

Corundum Trust Company sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 127 shares — an estimated $1.36K sold.

Corundum Trust Company first reported a position in OGN in Q3 2025 and held it in 1 quarter. The position peaked at $1.36K in Q3 2025. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

Corundum Trust Company reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
Corundum Trust Company sold 127 Organon & Co shares in Q4 2025, an estimated $1.36K.
Corundum Trust Company first reported a position in Organon & Co in Q3 2025 and held it in 1 quarter.
Corundum Trust Company's Organon & Co position peaked at $1.36K in Q3 2025.
634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Corundum Trust Company's 13F filing for Q4 2025, filed 20 Jan 2026.